The Complete Radiology Workup

  • Judy C. Boughey


Breast imaging plays an integral role in screening for and the diagnostic workup of breast cancer as well as the evaluation of breast complaints. The most commonly used breast imaging modalities are mammography, breast ultrasound (US), and breast magnetic resonance imaging (MRI). Once cancer is diagnosed, imaging is important in defining the extent of disease within the index breast (unifocal vs. multifocal disease) and also evaluation of the contralateral breast for surgical treatment planning. For breast conservation therapy, diagnostic imaging defines the extent of malignancy before definitive surgical resection and is used to monitor the breast for local recurrence after surgery.


Sentinel Lymph Node Core Needle Biopsy Fine Needle Aspiration Biopsy Breast Conservation Surgery Breast Magnetic Resonance Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kopans DB. The positive predictive value of mammography. AJR Am J Roentgenol. 1992;158:521–6.PubMedGoogle Scholar
  2. 2.
    Cardenosa G. Breast Imaging. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 89.Google Scholar
  3. 3.
    The American College of Radiology. BI-RADS® ATLAS and MQSA: Frequently Asked Questions. 2009. andSafety/BI-RADS®_atlas/BI-RADS®FAQs.aspx. Accessed 16 Feb 2009.Google Scholar
  4. 4.
    Fornage BD, Coan JD, David CL. Ultrasound-guided needle biopsy of the breast and other interventional procedures. Radiol Clin North Am. 1992;30:167–85.PubMedGoogle Scholar
  5. 5.
    Alvarez S, Anorbe E, Alcorta P, et al. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol. 2006;186:1342–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.PubMedCrossRefGoogle Scholar
  7. 7.
    Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Lavayssiere R, Cabee AE, Filmont JE. Positron emission tomography (PET) and breast cancer in clinical practice. Eur J Radiol. 2009;69(1):50.PubMedCrossRefGoogle Scholar
  9. 9.
    Hruska CB, Boughey JC, Phillips SW, et al. Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience. Am J Surg. 2008;196:470–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Silverstein MJ, Lagios MD, Recht A, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586–97.PubMedCrossRefGoogle Scholar
  11. 11.
    della Rovere GQ, Benson JR, Morgan M, et al. Localization of impalpable breast lesions–a surgical approach. Eur J Surg Oncol. 1996;22:478–82.PubMedCrossRefGoogle Scholar
  12. 12.
    Handel N, Silverstein MJ, Gamagami P, et al. Factors affecting mammographic visualization of the breast after augmentation mammaplasty. JAMA. 1992;268:1913–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Gray RJ, Forstner-Barthell AW, Pockaj BA, et al. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am J Surg. 2004;188:122–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer New York 2010

Authors and Affiliations

  1. 1.Department of SurgeryMayo ClinicRochesterUSA

Personalised recommendations